1. Home
  2. ARWR vs TPH Comparison

ARWR vs TPH Comparison

Compare ARWR & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • TPH
  • Stock Information
  • Founded
  • ARWR 2003
  • TPH 2009
  • Country
  • ARWR United States
  • TPH United States
  • Employees
  • ARWR N/A
  • TPH N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • TPH Homebuilding
  • Sector
  • ARWR Health Care
  • TPH Consumer Discretionary
  • Exchange
  • ARWR Nasdaq
  • TPH Nasdaq
  • Market Cap
  • ARWR 1.8B
  • TPH 2.8B
  • IPO Year
  • ARWR 1993
  • TPH N/A
  • Fundamental
  • Price
  • ARWR $13.25
  • TPH $31.78
  • Analyst Decision
  • ARWR Buy
  • TPH Strong Buy
  • Analyst Count
  • ARWR 11
  • TPH 5
  • Target Price
  • ARWR $41.44
  • TPH $42.80
  • AVG Volume (30 Days)
  • ARWR 1.7M
  • TPH 1.2M
  • Earning Date
  • ARWR 05-12-2025
  • TPH 04-24-2025
  • Dividend Yield
  • ARWR N/A
  • TPH N/A
  • EPS Growth
  • ARWR N/A
  • TPH 20.35
  • EPS
  • ARWR N/A
  • TPH 4.51
  • Revenue
  • ARWR $2,500,000.00
  • TPH $4,294,395,999.00
  • Revenue This Year
  • ARWR $4,380.43
  • TPH N/A
  • Revenue Next Year
  • ARWR $64.24
  • TPH $6.84
  • P/E Ratio
  • ARWR N/A
  • TPH $7.04
  • Revenue Growth
  • ARWR N/A
  • TPH 10.82
  • 52 Week Low
  • ARWR $9.57
  • TPH $27.90
  • 52 Week High
  • ARWR $30.41
  • TPH $47.78
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 49.13
  • TPH 56.87
  • Support Level
  • ARWR $13.00
  • TPH $30.58
  • Resistance Level
  • ARWR $14.97
  • TPH $31.84
  • Average True Range (ATR)
  • ARWR 0.77
  • TPH 0.92
  • MACD
  • ARWR 0.16
  • TPH 0.22
  • Stochastic Oscillator
  • ARWR 57.21
  • TPH 85.10

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.

Share on Social Networks: